{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:23:53Z","timestamp":1793294633527,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The lysin LysGH15, derived from the staphylococcal phage GH15, exhibits a wide lytic spectrum and highly efficient lytic activity against methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA). Here, we found that LysGH15 did not induce resistance in MRSA or methicillin-sensitive <jats:italic>S. aureus<\/jats:italic> (MSSA) strains after repeated treatment. Although LysGH15 triggered the generation of LysGH15-specific antibodies in mice, these antibodies did not block lytic activity <jats:italic>in vitro<\/jats:italic> (nor the binding capacity of LysGH15). More importantly, when the antibody titre was highest in mice immunized with LysGH15, a single intravenous injection of LysGH15 was sufficient to protect mice against lethal infection with MRSA. These results indicated that LysGH15-specific antibodies did not affect the killing efficiency of LysGH15 against MRSA <jats:italic>in vitro<\/jats:italic> or <jats:italic>in vivo<\/jats:italic>. LysGH15 also reduced pro-inflammatory cytokines in mice with lethal infections. Furthermore, a high-dose LysGH15 injection did not cause significant adverse effects or pathological changes in the main organs of treated animals. These results provide further evidence for the administration of LysGH15 as an alternative strategy for the treatment of infections caused by MRSA.<\/jats:p>","DOI":"10.1038\/srep29344","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T09:20:52Z","timestamp":1467883252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation"],"prefix":"10.1038","volume":"6","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruopeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liancheng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"BFsrep29344_CR1","doi-asserted-by":"crossref","unstructured":"Blodkamp, S. et al. In vitro activity of human and animal cathelicidins against livestock-associated methicillin-resistant Staphylococcus aureus. Veterinary microbiology, 10.1016\/j.vetmic.2015.09.018 (2015).","DOI":"10.1016\/j.vetmic.2015.09.018"},{"key":"BFsrep29344_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.tim.2015.03.007","volume":"23","author":"J Knox","year":"2015","unstructured":"Knox, J., Uhlemann, A. C. & Lowy, F. D. Staphylococcus aureus infections: transmission within households and the community. Trends Microbiol 23, 437\u2013444, 10.1016\/j.tim.2015.03.007 (2015).","journal-title":"Trends Microbiol"},{"key":"BFsrep29344_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMoa042683","volume":"352","author":"LG Miller","year":"2005","unstructured":"Miller, L. G. et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. The New England journal of medicine 352, 1445\u20131453, 10.1056\/NEJMoa042683 (2005).","journal-title":"The New England journal of medicine"},{"key":"BFsrep29344_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1128\/AAC.48.1.275-280.2004","volume":"48","author":"FC Tenover","year":"2004","unstructured":"Tenover, F. C. et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrobial agents and chemotherapy 48, 275\u2013280, 10.1128\/AAC.48.1.275-280.2004 (2004).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep29344_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.1090956","volume":"302","author":"LM Weigel","year":"2003","unstructured":"Weigel, L. M. et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302, 1569\u20131571, 10.1126\/science.1090956 (2003).","journal-title":"Science"},{"key":"BFsrep29344_CR6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.257.5073.1064","volume":"257","author":"HC Neu","year":"1992","unstructured":"Neu, H. C. The crisis in antibiotic resistance. Science 257, 1064\u20131073, 10.1126\/science.257.5073.1064 (1992).","journal-title":"Science"},{"key":"BFsrep29344_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S1471-4892(03)00109-7","volume":"3","author":"MC Enright","year":"2003","unstructured":"Enright, M. C. The evolution of a resistant pathogen\u2013the case of MRSA. Current opinion in pharmacology 3, 474\u2013479 (2003).","journal-title":"Current opinion in pharmacology"},{"key":"BFsrep29344_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrmicro3521","volume":"13","author":"V Thammavongsa","year":"2015","unstructured":"Thammavongsa, V., Kim, H. K., Missiakas, D. & Schneewind, O. Staphylococcal manipulation of host immune responses. Nat Rev Microbiol 13, 529\u2013543, 10.1038\/nrmicro3521 (2015).","journal-title":"Nat Rev Microbiol"},{"key":"BFsrep29344_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijfoodmicro.2008.08.010","volume":"128","author":"JM Obeso","year":"2008","unstructured":"Obeso, J. M., Martinez, B., Rodriguez, A. & Garcia, P. Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk. International journal of food microbiology 128, 212\u2013218, 10.1016\/j.ijfoodmicro.2008.08.010 (2008).","journal-title":"International journal of food microbiology"},{"key":"BFsrep29344_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/CCM.0b013e31819586a6","volume":"37","author":"M Witzenrath","year":"2009","unstructured":"Witzenrath, M. et al. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Critical care medicine 37, 642\u2013649, 10.1097\/CCM.0b013e31819586a6 (2009).","journal-title":"Critical care medicine"},{"key":"BFsrep29344_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1574-6968.2009.01541.x","volume":"294","author":"SC Becker","year":"2009","unstructured":"Becker, S. C. et al. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 294, 52\u201360, 10.1111\/j.1574-6968.2009.01541.x (2009).","journal-title":"FEMS Microbiol Lett"},{"key":"BFsrep29344_CR12","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1073\/pnas.061038398","volume":"98","author":"D Nelson","year":"2001","unstructured":"Nelson, D., Loomis, L. & Fischetti, V. A. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 98, 4107\u20134112, 10.1073\/pnas.061038398 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep29344_CR13","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1126\/science.1066869","volume":"294","author":"JM Loeffler","year":"2001","unstructured":"Loeffler, J. M., Nelson, D. & Fischetti, V. A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170\u20132172, 10.1126\/science.1066869 (2001).","journal-title":"Science"},{"key":"BFsrep29344_CR14","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature01026","volume":"418","author":"R Schuch","year":"2002","unstructured":"Schuch, R., Nelson, D. & Fischetti, V. A. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884\u2013889, 10.1038\/nature01026 (2002).","journal-title":"Nature"},{"key":"BFsrep29344_CR15","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2217\/fmb.12.97","volume":"7","author":"M Schmelcher","year":"2012","unstructured":"Schmelcher, M., Donovan, D. M. & Loessner, M. J. Bacteriophage endolysins as novel antimicrobials. Future microbiology 7, 1147\u20131171, 10.2217\/fmb.12.97 (2012).","journal-title":"Future microbiology"},{"key":"BFsrep29344_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/JCM.01144-10","volume":"49","author":"J Gu","year":"2011","unstructured":"Gu, J. et al. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 49, 111\u2013117, 10.1128\/JCM.01144-10 (2011).","journal-title":"J Clin Microbiol"},{"key":"BFsrep29344_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4161\/bbug.2.2.14883","volume":"2","author":"J Gu","year":"2011","unstructured":"Gu, J. et al. LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice. Bioengineered bugs 2, 96\u201399, 10.4161\/bbug.2.2.14883 (2011).","journal-title":"Bioengineered bugs"},{"key":"BFsrep29344_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00284-011-0018-y","volume":"63","author":"J Gu","year":"2011","unstructured":"Gu, J. et al. LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci. Current microbiology 63, 538\u2013542, 10.1007\/s00284-011-0018-y (2011).","journal-title":"Current microbiology"},{"key":"BFsrep29344_CR19","doi-asserted-by":"publisher","first-page":"e1004109","DOI":"10.1371\/journal.ppat.1004109","volume":"10","author":"J Gu","year":"2014","unstructured":"Gu, J. et al. Structural and biochemical characterization reveals LysGH15 as an unprecedented \u201cEF-hand-like\u201d calcium-binding phage lysin. PLoS pathogens 10, e1004109, 10.1371\/journal.ppat.1004109 (2014).","journal-title":"PLoS pathogens"},{"key":"BFsrep29344_CR20","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1128\/AAC.01625-09","volume":"54","author":"A Daniel","year":"2010","unstructured":"Daniel, A. et al. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 54, 1603\u20131612, 10.1128\/AAC.01625-09 (2010).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep29344_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1128\/AAC.00890-10","volume":"55","author":"M Pastagia","year":"2011","unstructured":"Pastagia, M. et al. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. Antimicrobial agents and chemotherapy 55, 738\u2013744, 10.1128\/AAC.00890-10 (2011).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep29344_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.mib.2008.09.012","volume":"11","author":"VA Fischetti","year":"2008","unstructured":"Fischetti, V. A. Bacteriophage lysins as effective antibacterials. Current opinion in microbiology 11, 393\u2013400, 10.1016\/j.mib.2008.09.012 (2008).","journal-title":"Current opinion in microbiology"},{"key":"BFsrep29344_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.scitotenv.2014.06.070","volume":"493","author":"X Bellanger","year":"2014","unstructured":"Bellanger, X., Guilloteau, H., Bonot, S. & Merlin, C. Demonstrating plasmid-based horizontal gene transfer in complex environmental matrices: a practical approach for a critical review. The Science of the total environment 493, 872\u2013882, 10.1016\/j.scitotenv.2014.06.070 (2014).","journal-title":"The Science of the total environment"},{"key":"BFsrep29344_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.scitotenv.2016.01.044","volume":"548\u2013549","author":"J Jutkina","year":"2016","unstructured":"Jutkina, J., Rutgersson, C., Flach, C. F. & Joakim Larsson, D. G. An assay for determining minimal concentrations of antibiotics that drive horizontal transfer of resistance. The Science of the total environment 548\u2013549, 131\u2013138, 10.1016\/j.scitotenv.2016.01.044 (2016).","journal-title":"The Science of the total environment"},{"key":"BFsrep29344_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.scitotenv.2013.08.100","volume":"468\u2013469","author":"S Kim","year":"2014","unstructured":"Kim, S. et al. Transfer of antibiotic resistance plasmids in pure and activated sludge cultures in the presence of environmentally representative micro-contaminant concentrations. The Science of the total environment 468\u2013469, 813\u2013820, 10.1016\/j.scitotenv.2013.08.100 (2014).","journal-title":"The Science of the total environment"},{"key":"BFsrep29344_CR26","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1073\/pnas.1107254109","volume":"109","author":"Z Qiu","year":"2012","unstructured":"Qiu, Z. et al. Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera. Proceedings of the National Academy of Sciences of the United States of America 109, 4944\u20134949, 10.1073\/pnas.1107254109 (2012).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep29344_CR27","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1128\/AAC.02526-12","volume":"57","author":"DB Gilmer","year":"2013","unstructured":"Gilmer, D. B., Schmitz, J. E., Euler, C. W. & Fischetti, V. A. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57, 2743\u20132750, 10.1128\/AAC.02526-12 (2013).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep29344_CR28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/jac\/dkg485","volume":"52","author":"I Jado","year":"2003","unstructured":"Jado, I. et al. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. The Journal of antimicrobial chemotherapy 52, 967\u2013973, 10.1093\/jac\/dkg485 (2003).","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"BFsrep29344_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.chom.2015.10.011","volume":"18","author":"S Muller","year":"2015","unstructured":"Muller, S. et al. Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates Immunopathology. Cell host & microbe 18, 604\u2013612, 10.1016\/j.chom.2015.10.011 (2015).","journal-title":"Cell host & microbe"},{"key":"BFsrep29344_CR30","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1128\/IAI.71.11.6199-6204.2003","volume":"71","author":"JM Loeffler","year":"2003","unstructured":"Loeffler, J. M., Djurkovic, S. & Fischetti, V. A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infection and immunity 71, 6199\u20136204 (2003).","journal-title":"Infection and immunity"},{"key":"BFsrep29344_CR31","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1086\/521305","volume":"196","author":"M Rashel","year":"2007","unstructured":"Rashel, M. et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. The Journal of infectious diseases 196, 1237\u20131247, 10.1086\/521305 (2007).","journal-title":"The Journal of infectious diseases"},{"key":"BFsrep29344_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1365-2958.2002.02889.x","volume":"44","author":"MJ Loessner","year":"2002","unstructured":"Loessner, M. J., Kramer, K., Ebel, F. & Scherer, S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Molecular microbiology 44, 335\u2013349 (2002).","journal-title":"Molecular microbiology"},{"key":"BFsrep29344_CR33","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.4049\/jimmunol.1302692","volume":"192","author":"MC Greenlee-Wacker","year":"2014","unstructured":"Greenlee-Wacker, M. C. et al. Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis. Journal of immunology 192, 4709\u20134717, 10.4049\/jimmunol.1302692 (2014).","journal-title":"Journal of immunology"},{"key":"BFsrep29344_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1128\/AEM.02581-15","volume":"82","author":"F Xia","year":"2015","unstructured":"Xia, F. et al. Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus. Applied and environmental microbiology 82, 87\u201394, 10.1128\/AEM.02581-15 (2015).","journal-title":"Applied and environmental microbiology"},{"key":"BFsrep29344_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ajpath.2015.07.025","volume":"186","author":"SJ Galli","year":"2016","unstructured":"Galli, S. J. The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis. The American journal of pathology 186, 212\u2013224, 10.1016\/j.ajpath.2015.07.025 (2016).","journal-title":"The American journal of pathology"},{"key":"BFsrep29344_CR36","doi-asserted-by":"publisher","first-page":"e1002619","DOI":"10.1371\/journal.ppat.1002619","volume":"8","author":"M Urb","year":"2012","unstructured":"Urb, M. & Sheppard, D. C. The role of mast cells in the defence against pathogens. PLoS pathogens 8, e1002619, 10.1371\/journal.ppat.1002619 (2012).","journal-title":"PLoS pathogens"},{"key":"BFsrep29344_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand, I., Hilpert, K. & Hancock, R. E. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature protocols 3, 163\u2013175, 10.1038\/nprot.2007.521 (2008).","journal-title":"Nature protocols"},{"key":"BFsrep29344_CR38","doi-asserted-by":"publisher","first-page":"e64671","DOI":"10.1371\/journal.pone.0064671","volume":"8","author":"L Rodriguez-Rubio","year":"2013","unstructured":"Rodriguez-Rubio, L. et al. The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance. PloS one 8, e64671, 10.1371\/journal.pone.0064671 (2013).","journal-title":"PloS one"},{"key":"BFsrep29344_CR39","doi-asserted-by":"publisher","first-page":"e0133196","DOI":"10.1371\/journal.pone.0133196","volume":"10","author":"K Maruyama","year":"2015","unstructured":"Maruyama, K. et al. ELISA-Based Detection System for Protein S K196E Mutation, a Genetic Risk Factor for Venous Thromboembolism. PloS one 10, e0133196, 10.1371\/journal.pone.0133196 (2015).","journal-title":"PloS one"},{"key":"BFsrep29344_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/hyb.2010.0009","volume":"29","author":"F Meng","year":"2010","unstructured":"Meng, F. et al. Production and characterization of a monoclonal antibody against spike protein of transmissible gastroenteritis virus. Hybridoma 29, 345\u2013350, 10.1089\/hyb.2010.0009 (2010).","journal-title":"Hybridoma"},{"key":"BFsrep29344_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12896-015-0203-3","volume":"15","author":"M Pleckaityte","year":"2015","unstructured":"Pleckaityte, M. et al. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen. BMC biotechnology 15, 85, 10.1186\/s12896-015-0203-3 (2015).","journal-title":"BMC biotechnology"},{"key":"BFsrep29344_CR42","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1021\/bi800251e","volume":"47","author":"GG Martin","year":"2008","unstructured":"Martin, G. G. et al. Structure and function of the sterol carrier protein-2 N-terminal presequence. Biochemistry 47, 5915\u20135934, 10.1021\/bi800251e (2008).","journal-title":"Biochemistry"},{"key":"BFsrep29344_CR43","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1128\/AAC.49.11.4789-4792.2005","volume":"49","author":"JM Entenza","year":"2005","unstructured":"Entenza, J. M., Loeffler, J. M., Grandgirard, D., Fischetti, V. A. & Moreillon, P. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrobial agents and chemotherapy 49, 4789\u20134792, 10.1128\/AAC.49.11.4789-4792.2005 (2005).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep29344_CR44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00253-014-6147-z","volume":"99","author":"Z Cui","year":"2015","unstructured":"Cui, Z. et al. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity. Applied microbiology and biotechnology 99, 667\u2013680, 10.1007\/s00253-014-6147-z (2015).","journal-title":"Applied microbiology and biotechnology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep29344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29344","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:54:11Z","timestamp":1672901651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep29344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,29]]}},"alternative-id":["BFsrep29344"],"URL":"https:\/\/doi.org\/10.1038\/srep29344","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]},"assertion":[{"value":"22 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29344"}}